|
|
 |
|
Viewing report
|
|
|
|
DNA Sequencing and PCR Markets
TriMark Publications, July 2008, Pages: 185
The focus of this report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the generally-accepted DNA-oriented analytical activities that are currently used today, such as enabling technologies like polymerase chain reaction (PCR). It examines these measurement technology platforms and their reagents and supplies as utilized in biotechnology research, pharmacology and healthcare. Generally, diagnostic tests which are marketed primarily as over-the-counter products directly to patients are not included in this study, although there is inevitably some overlap.
This examination will:
1) identify viable technology drivers through a comprehensive look at various platform technologies for molecular sequencing, including immunoassays electrophoretic methods, probe-based nucleic acid assays, microarrays and non-PCR sequencing
2) obtain a complete understanding of the chief molecular sequencing tests for predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic applications
3) discover feasible market opportunities via an identification of high-growth applications in different therapeutic areas, with a focus on the biggest and expanding markets–communicable diseases, cardiology and oncology
4) and focus on global industry development through an in-depth analysis of the major world markets for molecular sequencing, including forecasts for growth.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Also available
Microarray Markets
Bioinformatics Markets
Gene Expression Reagents Markets
Personalized Medicine
RNA Interference Markets
Genomics World Markets
Genetics Bundle
|
|
|
|
